AN OBSERVATIONAL STUDY REGARDING PRESCRIPTION EVENT MONITORING OF ANTI-HYPERTENSIVE MEDICATIONS AMONGST PATIENTS COMING TO A TERTIARY CARE CENTRE OF NORTHERN INDIAAbstract
Hypertension is now defined on the basis of systolic (SBP) and diastolic (DBP) blood pressure levels and classified into stages on the basis of the degree of elevation. The generally recognized cut point for hypertension is an average office BP of 140/90 mmHg or greater, which has been obtained by a recommended standard technique with an accurate manometer and has been confirmed on at least one other occasion. Hypertension is the main cause of high blood pressure (BP), and BP is a major public health issue in India and is rampant among both urban and rural populations. It is the key modifiable risk factor for many diseases. Prescription-event monitoring or PEM involves a methodology in which the safety of new medicines are studied that are used by general practitioners (GPs). PEM is an observational cohort form of pharmacovigilance that is non-interventional, in the sense that nothing happens to interfere with the doctor’s decision regarding which drug to prescribe for each individual patient. In this study, we focused on the prescription pattern of antihypertensive medications by the clinicians coming to the OPD of Department of Medicine, Rama Medical College, Kanpur.
S. Mishra *, N. Nigam, S. S. Ahmad, P. Shankar, S. Kumar, V. Kumar and S. Gupta
Department of Pharmacology, Rama Medical College Hospital & Research Centre, Kanpur, Uttar Pradesh, India.
14 December 2020
25 February 2021
18 March 2021
01 April 2021